Analyzing...
Loading company...
Nothing flagged for monitoring
“Operates in Agri Inputs — Fertilizers & Crop Protection.”
₹381 Cr revenue.
COGS 77.9%, employees 16.0%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | -21.6%▼ | 7.5% |
| ROCE | -9.7%▼ | 12.9% |
| Net Margin | -21.6%▼ | 5.3% |
| EBITDA Margin | -1.7%▼ | 11.2% |
| Debt To Equity | 0.89x▲ | 0.30x |
| Rev Growth 3yr | -17.4%▼ | 3.6% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹409 Cr +7.3% | ₹381 Cr -16.8% | ₹458 Cr -27.1% | ₹628 Cr -7.2% | ₹677 Cr +21.9% | ₹555 Cr +6.2% | ₹523 Cr +21.3% | ₹431 Cr |
| Other Income | ₹3 Cr -42.6% | ₹6 Cr -0.3% | ₹6 Cr -56.8% | ₹13 Cr +24.8% | ₹10 Cr +32.2% | ₹8 Cr -33.6% | ₹12 Cr +7.0% | ₹11 Cr |
| Total Income | ₹412 Cr +6.6% | ₹387 Cr -16.6% | ₹464 Cr -27.7% | ₹641 Cr -6.7% | ₹687 Cr +22.1% | ₹563 Cr +5.3% | ₹535 Cr +20.9% | ₹442 Cr |
| COGS | ₹262 Cr -11.9% | ₹297 Cr -7.0% | ₹319 Cr -20.4% | ₹401 Cr +3.7% | ₹387 Cr +13.1% | ₹342 Cr +1.0% | ₹339 Cr +21.1% | ₹279 Cr |
| ₹499 Cr -5.5% | ₹528 Cr +0.4% | ₹526 Cr -13.3% | ₹606 Cr +7.1% | ₹566 Cr +19.5% | ₹474 Cr +0.1% | ₹473 Cr +22.5% | ₹386 Cr | |
| Profit Before Tax | (₹89 Cr) +37.0% | (₹141 Cr) -128.3% | (₹62 Cr) ↓ Decline | ₹35 Cr -71.1% | ₹121 Cr +36.0% | ₹89 Cr +45.2% | ₹61 Cr +9.7% | ₹56 Cr |
| Exceptional Items | (₹2 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| ₹0.45 Cr ↑ Recovery | (₹6 Cr) +57.7% | (₹15 Cr) ↓ Decline | ₹9 Cr -70.1% | ₹31 Cr +30.2% | ₹24 Cr +73.6% | ₹14 Cr -31.3% | ₹20 Cr | |
| Net Profit | (₹89 Cr) +33.8% | (₹135 Cr) -187.3% | (₹47 Cr) ↓ Decline | ₹26 Cr -71.5% | ₹90 Cr +38.1% | ₹65 Cr +36.9% | ₹48 Cr +32.9% | ₹36 Cr |
| Profit (Owners) | (₹89 Cr) +33.8% | (₹135 Cr) -187.1% | (₹47 Cr) ↓ Decline | ₹26 Cr -71.5% | ₹90 Cr +38.1% | ₹65 Cr +36.9% | ₹48 Cr +32.9% | ₹36 Cr |
| Minority Interest | ₹0.04 Cr -2.7% | ₹0.04 Cr +5.7% | ₹0.04 Cr +32.8% | ₹0.03 Cr +20.8% | ₹0.02 Cr +20.6% | ₹0.02 Cr +24.4% | ₹0.02 Cr -44.1% | ₹0.03 Cr |
| Other Comprehensive Income | ₹0.01 Cr -95.7% | ₹0.17 Cr ↑ Recovery | (₹0.59 Cr) -168.5% | (₹0.22 Cr) | (₹0.01 Cr) +96.1% | (₹0.18 Cr) -7.9% | (₹0.17 Cr) ↓ Decline | ₹0.19 Cr |
| EPS | (₹42.03) | (₹60.12) | (₹20.94) | ₹11.41 | ₹40.12 | ₹29.07 | ₹21.24 | ₹15.99 |
| Diluted Shares | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the mar...
Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
Astec LifeSciences Limited has informed the Exchange about Credit Rating
Astec LifeSciences Limited has informed the Exchange regarding allotment of 577 securities pursuant to ESOP on February 24, 2026
Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the mar...
Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the mar...
Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
Astec LifeSciences Limited has informed the Exchange regarding a press release dated January 30, 2026, titled "PRESS RELEASE".
Astec LifeSciences Limited has informed the Exchange regarding Appointment of Mr Deepak Jawaharlal Ochani as Chief Financial Officer of the company w.e.f. April 01, 2026.
Astec LifeSciences Limited has informed the Exchange regarding Outcome of Board Meeting held on January 30, 2026.
Astec LifeSciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Astec LifeSciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Astec LifeSciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Astec LifeSciences Limited has informed the Exchange regarding appointment of Mr. Milind Bhangaonkar as General Manager Operations (Site Head) and a Senior Management Personnel of the Company with e...